Patrice Rioux
Förmögenhet: 3 M $ per 2026-05-31
Förmögenhet: 3 M $ per 2026-05-31
Patrice P.
Rioux is the founder of Thiogenesis Therapeutics, Inc., founded in 2016, serving as President, Chief Executive Officer & Director and also as Co-President, Chief Executive Officer & Director since 2016.
Dr. Rioux is the founder of Thiogenesis Therapeutics Corp., founded in 2018, serving as Chief Executive Officer & Director since 2022.
The current job is Chief Medical Officer at Monopar Therapeutics, Inc., starting in 2016.
Former jobs include Senior Vice President-Global Clinical Development at ArmaGen, Inc., Chief Medical Officer at FerroKin BioSciences, Inc., Chief Medical Officer at Horizon Pharmaceutical LLC, Chief Medical Officer at Raptor Pharmaceuticals Corp.
from 2009 to 2014, Vice President-Medical Research at Repligen Corp.
from 2000 to 2004, and Chief Medical Officer at Edison Pharmaceuticals, Inc. from 2005 to 2007.
Education includes a doctorate from Faculté de Médecine Paris and undergraduate studies at Pitié-Salpêtrière.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-07-28 | 6 770 069 ( 13,06 % ) | 3 M $ | 2026-05-31 | |
MONOPAR THERAPEUTICS INC 0,06 % | 2026-01-01 | 3 687 ( 0,06 % ) | 239 802 $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| MONOPAR THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2016-12-01 |
| THIOGENESIS THERAPEUTICS, CORP. | Grundare | 2018-05-03 |
Thiogenesis Therapeutics, Inc.
Thiogenesis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Grundare | 2016-02-01 |
| Företag | Position | Slut |
|---|---|---|
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Teknisk/Vetenskaplig/F&U Direktör | 2014-10-01 |
Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Teknisk/Vetenskaplig/F&U Direktör | 2007-12-01 |
| REPLIGEN CORPORATION | Teknisk/Vetenskaplig/F&U Direktör | 2004-01-01 |
ArmaGen, Inc.
ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Företagsledare/Principal | - |
| RAPTOR PHARMACEUTICAL CORP | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 11 |
|---|---|
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Edison Pharmaceuticals, Inc.
Edison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat mitochondrial diseases | Health Technology |
ArmaGen, Inc.
ArmaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops neurological therapies | Health Technology |
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and drug-delivery platforms | Health Technology |
FerroKin BioSciences, Inc.
FerroKin BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Offers iron chelator for the treatment of iron-overload in patients | Health Technology |
Horizon Pharmaceutical LLC
Horizon Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of life-altering therapeutics that treat debilitating and often fatal diseases | Health Technology |
Monopar Therapeutics, Inc.
Monopar Therapeutics, Inc. BiotechnologyHealth Technology Develops drugs for cancer disease | Health Technology |
Faculté de Médecine Paris
Faculté de Médecine Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thiogenesis Therapeutics, Inc.
Thiogenesis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Pitié-Salpêtrière
Pitié-Salpêtrière Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thiogenesis Therapeutics Corp.
Thiogenesis Therapeutics Corp. Financial ConglomeratesFinance Processes drugs in pharmaceutical preparations | Finance |
Välj din utgåva
All finansiell information anpassad till den nationella nivån